APOTHEEK URSEL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK URSEL
Largest movements
- Receivables within one year +€95,158
up €95,158 (+84.2%), from €112,966 to €208,124
of which Trade receivables: +€49,254
- Tangible fixed assets -€37,858
down €37,858 (-7.5%), from €502,250 to €464,392
of which Land and buildings: -€28,886
- Other debts +€121,595
up €121,595 (+16.4%), from €743,648 to €865,243
- Debts after one year -€104,242
down €104,242 (-26.7%), from €390,733 to €286,491
- Trade debts +€67,249
up €67,249 (+54.3%), from €123,790 to €191,039
- Current portion of long-term debt -€24,904
down €24,904 (-19.3%), from €129,144 to €104,241
- Gross operating margin -€32,616
down €32,616 (-15.6%), from €208,596 to €175,980
- Financial charges -€6,758
down €6,758 (-31.3%), from €21,607 to €14,848
of which Financial charges: -€4,758
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,647,622 | €1,707,741 | +€60,120 | +3.6% |
| Fixed assets | 21/28 | €1,329,565 | €1,291,708 | -€37,858 | -2.8% |
| Intangible fixed assets | 21 | €827,291 | €827,291 | = | 0.0% |
| Tangible fixed assets | 22/27 | €502,250 | €464,392 | -€37,858 | -7.5% |
| Land and buildings | 22 | €462,893 | €434,007 | -€28,886 | -6.2% |
| Plant, machinery and equipment | 23 | €36,680 | €28,601 | -€8,079 | -22.0% |
| Furniture and vehicles | 24 | €2,677 | €1,784 | -€893 | -33.4% |
| Financial fixed assets | 28 | €25 | €25 | = | 0.0% |
| Current assets | 29/58 | €318,056 | €416,034 | +€97,977 | +30.8% |
| Stocks and contracts in progress | 3 | €122,364 | €136,246 | +€13,882 | +11.3% |
| Stocks | 30/36 | €122,364 | €136,246 | +€13,882 | +11.3% |
| Amounts receivable within one year | 40/41 | €112,966 | €208,124 | +€95,158 | +84.2% |
| Trade receivables | 40 | €56,386 | €105,641 | +€49,254 | +87.4% |
| Other amounts receivable | 41 | €56,580 | €102,483 | +€45,903 | +81.1% |
| Cash at bank and in hand | 54/58 | €78,785 | €67,573 | -€11,212 | -14.2% |
| Deferred charges and accrued income | 490/1 | €3,941 | €4,092 | +€150 | +3.8% |
| Total equity and liabilities | 10/49 | €1,647,622 | €1,707,741 | +€60,120 | +3.6% |
| Equity | 10/15 | €210,948 | €209,491 | -€1,458 | -0.7% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €192,348 | €190,891 | -€1,458 | -0.8% |
| Distributable reserves | 133 | €192,348 | €190,891 | -€1,458 | -0.8% |
| Amounts payable | 17/49 | €1,436,673 | €1,498,251 | +€61,577 | +4.3% |
| Amounts payable after more than one year | 17 | €390,733 | €286,491 | -€104,242 | -26.7% |
| Financial debts | 170/4 | €390,733 | €286,491 | -€104,242 | -26.7% |
| Amounts payable within one year | 42/48 | €1,043,897 | €1,209,826 | +€165,928 | +15.9% |
| Current portion of amounts payable after more than one year | 42 | €129,144 | €104,241 | -€24,904 | -19.3% |
| Financial debts | 43 | €45,000 | €45,000 | = | 0.0% |
| Credit institutions | 430/8 | €45,000 | €45,000 | = | 0.0% |
| Trade debts | 44 | €123,790 | €191,039 | +€67,249 | +54.3% |
| Suppliers | 440/4 | €123,790 | €191,039 | +€67,249 | +54.3% |
| Advances received on contracts in progress | 46 | €118 | €833 | +€715 | +606% |
| Taxes, remuneration and social security | 45 | €2,197 | €3,470 | +€1,273 | +57.9% |
| Taxes | 450/3 | €2,197 | €3,470 | +€1,273 | +57.9% |
| Other amounts payable | 47/48 | €743,648 | €865,243 | +€121,595 | +16.4% |
| Accrued charges and deferred income | 492/3 | €2,042 | €1,934 | -€109 | -5.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €38,667 | €39,055 | +€388 | +1.0% |
| Other operating charges | 640/8 | €2,396 | €2,194 | -€202 | -8.4% |
| Gross operating margin | 9900 | €208,596 | €175,980 | -€32,616 | -15.6% |
| Operating profit (loss) | 9901 | €167,533 | €134,731 | -€32,802 | -19.6% |
| Financial income | 75/76B | €172 | €189 | +€17 | +9.9% |
| Recurring financial income | 75 | €172 | €189 | +€17 | +9.9% |
| Financial charges | 65/66B | €21,607 | €14,848 | -€6,758 | -31.3% |
| Recurring financial charges | 65 | €19,607 | €14,848 | -€4,758 | -24.3% |
| Non-recurring financial charges | 66B | €2,000 | - | -€2,000 | |
| Profit (loss) for the period before taxes | 9903 | €146,099 | €120,072 | -€26,027 | -17.8% |
| Income taxes | 67/77 | €1,922 | €1,529 | -€392 | -20.4% |
| Profit (loss) for the period | 9904 | €144,177 | €118,542 | -€25,635 | -17.8% |
| Profit (loss) for the period to be appropriated | 9905 | €144,177 | €118,542 | -€25,635 | -17.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.